CA2250863A1 - Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux - Google Patents
Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretrovirauxInfo
- Publication number
- CA2250863A1 CA2250863A1 CA002250863A CA2250863A CA2250863A1 CA 2250863 A1 CA2250863 A1 CA 2250863A1 CA 002250863 A CA002250863 A CA 002250863A CA 2250863 A CA2250863 A CA 2250863A CA 2250863 A1 CA2250863 A1 CA 2250863A1
- Authority
- CA
- Canada
- Prior art keywords
- acridone
- antineoplastic
- independently
- derived compounds
- compounds useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- GDALETGZDYOOGB-UHFFFAOYSA-N Acridone Natural products C1=C(O)C=C2N(C)C3=CC=CC=C3C(=O)C2=C1O GDALETGZDYOOGB-UHFFFAOYSA-N 0.000 title abstract 2
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 title abstract 2
- 229940034982 antineoplastic agent Drugs 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 230000000118 anti-neoplastic effect Effects 0.000 title 1
- 229940124522 antiretrovirals Drugs 0.000 title 1
- 239000003903 antiretrovirus agent Substances 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002525550A CA2525550C (fr) | 1996-04-12 | 1997-04-09 | Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1532696P | 1996-04-12 | 1996-04-12 | |
| US3505097P | 1997-01-22 | 1997-01-22 | |
| US60/015,326 | 1997-01-22 | ||
| US60/035,050 | 1997-01-22 | ||
| PCT/US1997/007070 WO1997038999A1 (fr) | 1996-04-12 | 1997-04-09 | Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002525550A Division CA2525550C (fr) | 1996-04-12 | 1997-04-09 | Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2250863A1 true CA2250863A1 (fr) | 1997-10-23 |
| CA2250863C CA2250863C (fr) | 2006-02-14 |
Family
ID=35892349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002250863A Expired - Fee Related CA2250863C (fr) | 1996-04-12 | 1997-04-09 | Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2250863C (fr) |
-
1997
- 1997-04-09 CA CA002250863A patent/CA2250863C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2250863C (fr) | 2006-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT892801E (pt) | Compostos derivados de acridona uteis como agentes antineoplasicos e antiretrovirais | |
| BR9815166A (pt) | "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral" | |
| NO178930C (no) | Analogifremgangsmåte ved fremstilling av antivirale pyrimidinnukleosider | |
| PE10399A1 (es) | Derivados de aminoacidos | |
| WO2004046159A8 (fr) | Derives nucleosidiques antiviraux | |
| DE69909756D1 (de) | Antivirale pyrimidinderivate | |
| CA2433591A1 (fr) | Nouveaux derives de phosphonate nucleosidique acyclique, sels de ces derniers et procede de preparation de ces derniers | |
| DE60101223D1 (de) | Antivirale pyrimidin nucleoside derivate | |
| ES2086376T3 (es) | Nucleosidos pirimidinicos antivirales. | |
| ES2191075T3 (es) | 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv. | |
| WO1999058526A8 (fr) | Nouveaux derives d'acide 2,5-pyridinecarboxylique | |
| MY117314A (en) | Process for the preparation of 2'-fluoro-5-methyl-(beta)-l- arabino-furanosyluridine. | |
| AU7677891A (en) | Inhibition of disease associated with immunodeficiency virus infection | |
| AU643987B2 (en) | Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents | |
| CA2250863A1 (fr) | Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux | |
| AU3530293A (en) | Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV) | |
| CA2195125A1 (fr) | Agents antiviraux a base de difluorostatone | |
| ATE198746T1 (de) | Pyrimidinderivate und pharmazeutische zusammensetzungen | |
| WO2001006986A3 (fr) | Analogues uracile 5-(e)- bromovinyl et nucleosides pyrimidines associes ayant la fonction d'agents anti-viraux et procedes associes | |
| CA2525550A1 (fr) | Composes derives de l'acridone utiles en tant qu'agents antineoplasiques et antiretroviraux | |
| ZA932271B (en) | Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150409 |